Any fatty acid ester in which the carboxylic acid component is lauric acid.
ChEBI ID: 87659
| Member | Definition | Role |
|---|---|---|
| 1,2-didodecanoyl-glycero-3-phosphocholine | A phosphatidylglycerol in which the phosphatidyl acyl groups are both lauroyl. | dilauroyl phosphatidylglycerol |
| aripiprazole lauroxil | A dodecanoate ester obtained by formal condensation of the carboxy group of dodecanoic acid with the hydroxy group of 7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-2-oxo-3,4-dihydroquinolin-1(2H)-yl]methanol. A prodrug for aripiprazole, it is used for treatment of schizophrenia. | aripiprazole lauroxil |
| kdo2-lipid a | (Kdo)2-lipid A (E. coli) | |
| lauric acid methyl ester | A fatty acid methyl ester of lauric acid. | methyl laurate |
| lauroylcarnitine | An O-acyl-L-carnitine in which the acyl group is specified as lauroyl (dodecanoyl). | O-lauroyl-L-carnitine |
| lipid a | The glycolipid moiety of the lipopolysaccharide produced by E. coli. | lipid A (E. coli) |
| monolaurin | A 1-monoglyceride with dodecanoyl (lauroyl) as the acyl group. | 1-monolauroylglycerol; rac-1-monolauroylglycerol |
| trilaurin | A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by lauric (dodecanoic) acid. | trilaurin |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 689 (16.92) | 18.7374 |
| 1990's | 971 (23.85) | 18.2507 |
| 2000's | 966 (23.73) | 29.6817 |
| 2010's | 1,180 (28.99) | 24.3611 |
| 2020's | 265 (6.51) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 150 (3.55%) | 5.53% |
| Reviews | 354 (8.37%) | 6.00% |
| Case Studies | 11 (0.26%) | 4.05% |
| Observational | 4 (0.09%) | 0.25% |
| Other | 3,712 (87.73%) | 84.16% |